These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 29042427)

  • 1. Predictors of Death in Adults With Duchenne Muscular Dystrophy-Associated Cardiomyopathy.
    Cheeran D; Khan S; Khera R; Bhatt A; Garg S; Grodin JL; Morlend R; Araj FG; Amin AA; Thibodeau JT; Das S; Drazner MH; Mammen PPA
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29042427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterozygous Cystic Fibrosis Transmembrane Regulator Gene Missense Variants Are Associated With Worse Cardiac Function in Patients With Duchenne Muscular Dystrophy.
    Jiang X; Shao Y; Araj FG; Amin AA; Greenberg BM; Drazner MH; Xing C; Mammen PPA
    J Am Heart Assoc; 2020 Oct; 9(19):e016799. PubMed ID: 33003980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac phenotype determines survival in Duchenne muscular dystrophy.
    Birnkrant DJ; Ararat E; Mhanna MJ
    Pediatr Pulmonol; 2016 Jan; 51(1):70-6. PubMed ID: 26097149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A current approach to heart failure in Duchenne muscular dystrophy.
    D'Amario D; Amodeo A; Adorisio R; Tiziano FD; Leone AM; Perri G; Bruno P; Massetti M; Ferlini A; Pane M; Niccoli G; Porto I; D'Angelo GA; Borovac JA; Mercuri E; Crea F
    Heart; 2017 Nov; 103(22):1770-1779. PubMed ID: 28668906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiomyopathy of Duchenne muscular dystrophy: current understanding and future directions.
    Spurney CF
    Muscle Nerve; 2011 Jul; 44(1):8-19. PubMed ID: 21674516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Factors for Cardiac and Non-cardiac Causes of Death in Males with Duchenne Muscular Dystrophy.
    Wittlieb-Weber CA; Knecht KR; Villa CR; Cunningham C; Conway J; Bock MJ; Gambetta KE; Lal AK; Schumacher KR; Law SP; Deshpande SR; West SC; Friedland-Little JM; Lytrivi ID; McCulloch MA; Butts RJ; Weber DR; Johnson JN
    Pediatr Cardiol; 2020 Apr; 41(4):764-771. PubMed ID: 32016582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac Involvement in Duchenne Muscular Dystrophy and Related Dystrophinopathies.
    Mavrogeni SI; Markousis-Mavrogenis G; Papavasiliou A; Papadopoulos G; Kolovou G
    Methods Mol Biol; 2018; 1687():31-42. PubMed ID: 29067654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Management of myocardial damage in muscular dystrophy].
    Tamura T
    Brain Nerve; 2011 Nov; 63(11):1217-28. PubMed ID: 22068474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Noninvasive Ventilation on Lung Volumes and Maximum Respiratory Pressures in Duchenne Muscular Dystrophy.
    Brasil Santos D; Vaugier I; Boussaïd G; Orlikowski D; Prigent H; Lofaso F
    Respir Care; 2016 Nov; 61(11):1530-1535. PubMed ID: 27794082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Duchenne Muscular Dystrophy Cardiomyopathy.
    Soslow JH; Xu M; Slaughter JC; Crum K; Chew JD; Burnette WB; Su YR; Tomasek K; Parra DA; Markham LW
    J Card Fail; 2019 Apr; 25(4):259-267. PubMed ID: 30763738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiomyopathy in Duchenne Muscular Dystrophy: Current Value of Clinical, Electrophysiological and Imaging Findings in Children and Teenagers.
    Dittrich S; Tuerk M; Haaker G; Greim V; Buchholz A; Burkhardt B; Fujak A; Trollmann R; Schmid A; Schroeder R
    Klin Padiatr; 2015 Jul; 227(4):225-31. PubMed ID: 26058601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Why are some patients with Duchenne muscular dystrophy dying young: An analysis of causes of death in North East England.
    Van Ruiten HJ; Marini Bettolo C; Cheetham T; Eagle M; Lochmuller H; Straub V; Bushby K; Guglieri M
    Eur J Paediatr Neurol; 2016 Nov; 20(6):904-909. PubMed ID: 27524390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin 1 Receptor-Like 1 Protein (ST2) is a Potential Biomarker for Cardiomyopathy in Duchenne Muscular Dystrophy.
    Anderson J; Seol H; Gordish-Dressman H; Hathout Y; Spurney CF;
    Pediatr Cardiol; 2017 Dec; 38(8):1606-1612. PubMed ID: 28821969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial effects of beta-blockers and angiotensin-converting enzyme inhibitors in Duchenne muscular dystrophy.
    Ogata H; Ishikawa Y; Ishikawa Y; Minami R
    J Cardiol; 2009 Feb; 53(1):72-8. PubMed ID: 19167641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical profiles and prognosis of acute heart failure in adult patients with dystrophinopathies on home mechanical ventilation.
    Fayssoil A; Yaou RB; Ogna A; Leturcq F; Nardi O; Clair B; Wahbi K; Lofaso F; Laforet P; Duboc D; Orlikowski D; Annane D
    ESC Heart Fail; 2017 Nov; 4(4):527-534. PubMed ID: 29154419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. All-cause mortality and cardiovascular outcomes with prophylactic steroid therapy in Duchenne muscular dystrophy.
    Schram G; Fournier A; Leduc H; Dahdah N; Therien J; Vanasse M; Khairy P
    J Am Coll Cardiol; 2013 Mar; 61(9):948-54. PubMed ID: 23352781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between cardiac involvement and long-term clinical outcomes in patients with Duchenne muscular dystrophy.
    Cha JJ; Kim IS; Kim JY; Choi EY; Min PK; Yoon YW; Lee BK; Hong BK; Kwon HM; Cho HE; Choi WA; Kang SW; Rim SJ
    ESC Heart Fail; 2022 Aug; 9(4):2199-2206. PubMed ID: 35579098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiomyopathy in Duchenne muscular dystrophy: pathogenesis and therapeutics.
    Fayssoil A; Nardi O; Orlikowski D; Annane D
    Heart Fail Rev; 2010 Jan; 15(1):103-7. PubMed ID: 19943106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac involvement in Fukuyama muscular dystrophy is less severe than in Duchenne muscular dystrophy.
    Yamamoto T; Taniguchi-Ikeda M; Awano H; Matsumoto M; Lee T; Harada R; Imanishi T; Hayashi N; Sakai Y; Morioka I; Takeshima Y; Iijima K; Saegusa J; Toda T
    Brain Dev; 2017 Nov; 39(10):861-868. PubMed ID: 28578814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duchenne muscular dystrophy patients: troponin leak in asymptomatic and implications for drug toxicity studies.
    Sheybani A; Crum K; Raucci FJ; Burnette WB; Markham LW; Soslow JH
    Pediatr Res; 2022 Dec; 92(6):1613-1620. PubMed ID: 34429516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.